Cybin Inc. (NEO:CYBN) (OTCQB:CLXPF) (“Cybin”), a biotechnology company focused on progressing psychedelic therapeutics, today announced that it has successfully demonstrated… Read More…..
Excerpt only …
READ MORE BELOW
Source : Cybin Demonstrates Proof of Concept of its Deuterated Tryptamines for the Treatment of Depression and Addiction
reposted by Cannabis News World